STAT+: ARPA-H to invest $62 million to develop FDA-authorized AI to help treat heart failure

ARPA-H, the government agency that funds cutting-edge health research, plans to commit $62.7 million to develop artificial intelligence bots that direct treatment of heart failure. Among the goals of the program, called ADVOCATE, is to produce partially autonomous AI devices authorized by the Food and Drug Administration to help treat patients, including assessing symptom severity, prescribing drugs, and ordering lab tests.  ARPA-H on Wednesday announced the first batch of awards to health tech ...